Cite
HARVARD Citation
Engelina, S. et al. (2020). Brentuximab a novel antibody therapy: real‐world use confirms efficacy and tolerability for CD30‐positive cutaneous lymphoma. British journal of dermatology. pp. 799-800. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Engelina, S. et al. (2020). Brentuximab a novel antibody therapy: real‐world use confirms efficacy and tolerability for CD30‐positive cutaneous lymphoma. British journal of dermatology. pp. 799-800. [Online].